Dr. Patterson-Fortin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-3779Fax+1 617-632-5822
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2018 - 2021
Johns Hopkins UniversityResidency, Internal Medicine, 2015 - 2018
University of Western OntarioClass of 2015
Certifications & Licensure
UT State Medical License 2024 - 2026
MA State Medical License 2018 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 9 citationsNovobiocin blocks nucleic acid binding to Polθ and inhibits stimulation of its ATPase activity.Aleem Syed, Frantisek Filandr, Jeffrey Patterson-Fortin, Albino Bacolla, Ramya Ravindranathan
Nucleic Acids Research. 2023-10-13 - 44 citationsExploiting the Microhomology-Mediated End-Joining Pathway in Cancer Therapy.Jeffrey Patterson-Fortin, Alan D. D'Andrea
Cancer Research. 2020-11-01 - 15 citationsPolymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer.Jeffrey Patterson-Fortin, Heta Jadhav, Constantia Pantelidou, Tin Phan, Carter Grochala
Nature Communications. 2023-03-13
Press Mentions
Novobiocin Attacks BRCA-Mutated Cancer Cells from Within and Without, Study ShowsMarch 14th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
